Loading company…
Kitchener, Canada biotech specializing in antibody sequencing and characterization without hybridoma or DNA information.
Founded in 2015 and headquartered in Kitchener, Ontario, Canada, Rapid Novor, Inc. provides antibody discovery and characterization, including sequencing of antibodies from small protein samples without hybridoma or DNA information. Its services include antibody sequencing, epitope mapping and surface plasmon resonance testing for over 650 clients in pharmaceuticals, biotechnology and diagnostics. The company raised USD 5.0 mn in Series A funding led by Co-Win Ventures on July 28, 2020. Bin Ma is the founder and Mingjie Xie is CEO.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in